108835 ⎘
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof Inactivation or attenuation; Producing viral sub-units
Sub-classes:STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT
#2POLYNUCLEOTIDES AND LENTIVIRAL VECTORS EXPRESSING NON-STRUCTURAL ANTIGENS OF A FLAVIVIRUS SELECTED FROM THE GROUP OF DENV, ZIKV AND YFV, INDUCING PROTECTIVE CD8+ T-CELL IMMUNITY IN A HOST
#3Mammalian Cell Line for the Production of Modified Vaccinia Virus Ankara (MVA)
#4METHODS FOR TREATING CANCER WITH HYPERACTIVE ADAR ENZYMES
#5INFLUENZA VIRUS VACCINATION REGIMENS
#6SELF-CLEAVING POLYPROTEINS AND USES THEREOF
#7METHODS AND COMPOSITIONS FOR THE PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) VECTORS
#8BROAD SPECTRUM VIRUS-TRAPPING NANOSHELLS
#9VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#10VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
#11METHOD FOR ATTENUATING INFLUENZA VIRUS BY SYNONYMOUS MUTATION AND DELETION MUTATION, AND ATTENUATED INFLUENZA VIRUS STRAIN AND USE
#12VECTOR PRODUCTION
#13IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION
#14Attenuated Virus of Flavivirus Virus and Use Thereof
#15METHOD FOR PRODUCING AN ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGEN CORRESPONDING TO THE INACTIVATED SARS-COV-2 VIRUS, ANTIGENIC COMPOSITION, KITS, AND USES THEREOF
#16CD1 PEPTIDE-EPITOPE FOR USE IN THE TREATMENT OF A DISEASE CAUSED BY AN INTRACELLULAR PATHOGEN
#17Production of High Titer Recombinant Vesicular Stomatitis Virus in Suspension Cell Culture
#18COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF
#19Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
#20Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines
#21Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
#22Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#23Computational reduction vaccine for Covid-19 Bin75
#24Vector production
#25THERAPEUTIC VACCINE FOR THE TREATMENT OF PAPILLOMAVIRUS LESIONS
#26METHOD FOR ACTIVATING IMMUNOCYTES IN VITRO
#27Use of Syncytin for Targeting Drug and Gene Delivery to Lung Tissue
#28Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
#29Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
#30CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
#31Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
#32Zika virus strains for treatment of glioma
#33Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation
#34Viral gene therapy as treatment for cholesterol storage disease or disorder
#35Therapeutic vaccine for the treatment of papillomavirus lesions
#36Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions
#37METHOD FOR RAPID GENERATION OF AN ATTENUATED RNA VIRUS
#38ADENOVIRUS CONTROL VIRUS
#39Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia
#40METHODS FOR INACTIVATING, ON MEDICAL INSTRUMENTS AND DEVICES, VIRUSES CONTAINING RNA AND DNA, AND APPARATUSES FOR IMPLEMENTATING SAME
#41Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#42ROTAVIRUS-LIKE PARTICLE PRODUCTION IN PLANTS
#43Temperature-sensitive attenuated FMDV strains, construction method and application thereof
#44Polypeptide carrier for presenting target polypeptide and uses thereof
#45Chimeric norovirus P particle and preparation and use thereof
#46Purification of recombinant EV71 virus-like particle and method for preparing vaccine thereof
#47Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
#48Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors
#49Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
#50Duck enteritis virus and the uses thereof
#51Duck enteritis virus and the uses thereof
#52Duck enteritis virus and the uses thereof
#53Duck Enteritis Virus and the uses thereof
#54Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#55Attenuated virus having multiple hosts
#56Feline calicivirus vaccine
#57Viable viruses with foreign tags
#58Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#59Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
#60FCV recombinant vaccines and uses thereof
#61Host regulatory factor that enhances replication and/or propagation of vaccinia virus
#62Method for rapid generation of an attenuated RNA virus
#63IMPROVED NEGATIVE-STRAND RNA VIRAL VECTOR
#64Duck enteritis virus and the uses thereof
#65Methods and compositions for treating herpes
#66Modified CPMV enhancer elements
#67VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#68Constructs for continuous monitoring of live cells
#69Rotavirus-like particle production in plants
#70Influenza virus vaccination regimens
#71JC polyomavirus VLP (virus-like particle) with a targeting peptide
#72Viral RNA segments as immunomodulatory agents and vaccine components
#73Method for preparing a vaccine antigen, resulting vaccine antigen and uses
#74Cell identification method
#75HSV VACCINES
#76Method for enhancing immunogenicity of epitope peptide of HPV antigen, virus-like particle, and method for preparing HPV vaccine
#77Vector production
#78Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
#79Methods for inactivating, on medical instruments and devices, viruses containing RNA and DNA, and apparatuses for implementating same
#80Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#81Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#82Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#83Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia
#84Vaccines for diseases caused by viruses of the family of reoviridae
#85Live attenuated vaccines for influenza viruses
#86Attenuated influenza vaccines and uses thereof
#87Attenuated swine influenza vaccines and methods of making and use thereof
#88Porcine pseudorabies virus, vaccine composition and preparation method and use thereof
#89Method for in-vitro preparation of double-layered virus-like particles of rotavirus
#90Immunization with rabies virus vector expressing foreign protein antigen
#91Pathogenic phlebovirus isolates and compositions and methods of use
#92Process for purifying VLPs
#93PERMISSIVE CELLS AND USES THEREOF
#94Flavivirus envelope protein mutations affecting virion disassembly
#95Method for inactivating viruses with slightly acidic arginine
#96Attenuated swine influenza vaccines and methods of making and use thereof
#97Anti-cancer adenoviruses
#98FELINE PICORNA VIRUS AND USES THEREOF
#99Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#100INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
#101Permissive cells and uses thereof
#102Development of influenza A antivirals
#103Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#104Method for inactivating viruses with slightly acidic arginine
#105Methods of terminal sterilization of biological products
#106Development of influenza A antivirals
#107Attenuated dengue virus comprising mutations in the NS3 gene
#108Preparation of immunoglobulin
#109Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses